REV 25 mg (Revlimid 25 mg)
Generic Name: lenalidomide
Pill with imprint REV 25 mg is White, Capsule-shape and has been identified as Revlimid 25 mg. It is supplied by Celgene Corporation.
Revlimid is used in the treatment of multiple myeloma; follicular lymphoma; lymphoma; myelodysplastic diseases; mantle cell lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for REV 25 mg
Revlimid
- Generic Name
- lenalidomide
- Imprint
- REV 25 mg
- Strength
- 25 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics, Other immunosuppressants
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0425
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate
Note: Inactive ingredients may vary.
More about Revlimid (lenalidomide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 14 Reviews
- Drug class: miscellaneous antineoplastics
- FDA Alerts (2)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
